OABIW vs NXTC: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

NXTC has stronger fundamentals based on our AI analysis.

OABIW
OmniAb, Inc.
STRONG SELL
85%
Confidence
VS
NXTC
NextCure, Inc.
SELL
78%
Confidence

OABIW vs NXTC Fundamental Comparison

Metric OABIW NXTC
Revenue $18.7M $22.4M
Net Income $-64.8M $-55.8M
Net Margin -347.0% -249.5%
ROE -24.3% -159.8%
ROA -21.5% -111.3%
Current Ratio 4.02x 4.14x
Debt/Equity 0.00x 0.00x
EPS $-0.57 $-19.65

Green = Better metric | Red = Weaker metric

View Full OABIW Analysis →
View Full NXTC Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OABIW vs AAPL NXTC vs MSFT OABIW vs GOOGL NXTC vs AMZN

OABIW vs NXTC: Frequently Asked Questions

Is OABIW or NXTC a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), NXTC has stronger fundamentals. OABIW is rated STRONG SELL (85% confidence) while NXTC is rated SELL (78% confidence). This is not investment advice.

How does OABIW compare to NXTC fundamentally?

OmniAb, Inc. has ROE of -24.3% vs NextCure, Inc.'s -159.8%. Net margins are -347.0% vs -249.5% respectively.

Which stock pays higher dividends, OABIW or NXTC?

OABIW has a dividend yield of N/A or no dividend while NXTC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OABIW or NXTC for long term?

For long-term investing, consider that OABIW has STRONG SELL rating with 85% confidence, while NXTC has SELL rating with 78% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OABIW vs NXTC?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OABIW vs NXTC, the AI consensus favors NXTC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.